Back
I-MAB 10K Form
Sell
39
IMAB
I-MAB
Last Price:
1.76
Seasonality Move:
22.98%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IMAB News And Ratings
See the #1 stock for the next 7 days that we like better than IMAB
IMAB Financial Statistics
Sales & Book Value
| Annual Sales: | $3.91M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.08 |
| Price / Book: | 0.59 |
Profitability
| EPS (TTM): | -3.80570 |
|---|---|
| Net Income (TTM): | $-315.57M |
| Gross Margin: | $3.91M |
| Return on Equity: | -61.87% |
| Return on Assets: | -42.93% |
I-MAB Earnings Forecast
Key I-MAB Financial Ratios
- The Gross Profit Margin over the past 5 years for IMAB is 100.00%.
- The Selling, General & Administrative Expenses for IMAB have been equal to 1,638.75% of Gross Profit Margin.
- The Research & Development expenses have been 2,932.45% of Revenue.
- The Interest Expense is -0.05% of Operating Income.
- The Net Earning history of IMAB is -5,302.04% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 3 years.
I-MAB Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IMAB |
| Website: | i-mabbiopharma.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 5.67 |
| Quick Ratio: | 5.67 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |